ArticleClinical & experimental metastasis2015

Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.

Ingrid Moen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.